Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive rats

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 7000-7007

  Levick, Scott ^a   Loch, David ^a   Rolfe, Barbara ^a   Reid, Robert C ^a   Fairlie, David P ^a   Taylor, Stephen M ^a   Brown, Lindsay ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 BENZYLOXYPHENYL)(PHENYLHEPTANOYLAMINO)PENTANOIC ACID; COLLAGEN; GROUP IIA SECRETORY PHOSPHOLIPASE A2; ILIUM XYLAZIL; KH 064; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; UNCLASSIFIED DRUG; ZOLETIL;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HYPERTENSION; INFLAMMATORY CELL; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA;

EID: 33646866410     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.7000     Document Type: Article

References (61)

1. Weber, K. T., C. G. Brilla, and J. S. Janicki. 1993. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc. Res. 27: 341-348.
2. Hinglais, N., D. Heudes, A. Nicoletti, C. Mandel, M. Laurent, J. Bariety, and J. Michel. 1994. Colocalization of myocardial fibrosis and inflammatory cells in rats. Lab. Invest. 70: 286-294.
3. Nicoletti, A., D. Heudes, C. Mandet, N. Hinglais, J. Bariety, and J. Michel. 1996. Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats. Cardiovasc. Res. 32: 1096-1107.
4. Tomita, H., K. Egashira, M. Kubo-Inoue, M. Usui, M. Koyanagi, H. Shimokawa, M. Takeya, T. Yoshimura, and A. Takeshita. 1998. Inhibition of NO synthases induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. Arterioscler. Thromb. Vasc. Biol. 18: 1456-1464.
5. Sun, Y., J. Zhang, L. Lu, S. S. Chen, MT. Quinn, and K. T. Weber. 2002. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am. J. Pathol. 161: 1773-1781.
6. Rocha, R., A. E. Rudolph, G. E. Frierdich, D. A. Nachowiak, B. K. Kekec, A. G. Blomme, E. G. McMahon, and J. A. Delyani. 2002. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am. J. Physiol. 283: H1802-H1810.
7. Sun, Y., J. Zhang, L. Lu, M. P. Bedigian, A. D. Robinson, and K. T. Weber. 2004. Tissue angiotensin II in the regulation of inflammatory and fibrinogenic components of repair in the rat heart. J. Lab. Clin. Med. 143: 41-51.
8. Kagitani, S., H. Ueno, S. Hirade, T. Takahashi, M. Takata, and H. Inoue. 2004. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats. J. Hypertens. 22: 1007-1015.
9. Kuwahara, F., H. Kai, K. Tokuda, M. Takeya, A. Takeshita, K. Egashira, and T. Imaizumi. 2004. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43: 739-745.
10. 2 enzymes. Prostaglandins Other Lipid Mediat. 68-69: 3-58.
11. 2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 1: 739-754.
12. Cruz-Gervis, R., A. A. Stecenko, R. Dworski, K. B. Lane, J. E. Loyd, R. Pierson, G. King, and K. L. Brigham. 2002. Altered prostanoid production by fibroblasts cultured from the lungs of human subjects with idiopathic pulmonary fibrosis. Respir. Res. 3: 17-22.
13. Wen, Y., J. Gu, X. Peng, G. Zang, and J. Nadler. 2003. Overexpression of 12-lipoxygenase and cardiac fibroblast hypertrophy. Trends Cardiovasc. Med. 13: 129-136.
14. 2. J. Biol. Chem. 277: 48535-48549.
15. 2 group IIA. Curr. Med. Chem. 12: 3011-3026.
16. 2 antigen in arthritic synovium. Ann. Rheum. Dis. 57: 550-558.
17. 2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes. J. Immunol. 165: 2790-2797.
18. Mayer, J., B. Rau, M. Grewe, M. H. Schoenberg, T. J. Nevalainen, and B. G. Beger. 1998. Secretory phospholipase A2 in patients with infected pancreatic necroses in acute pancreatitis. Pancreas 17: 272-277.
19. 2 activities are decreased during early but increased during late phases of sepsis in rat heart. J. Surg. Res. 75: 165-169.
20. 2 predict coronary events in patients with coronary artery disease. Circulation 100: 1280-1284.
21. Leong, L. L., M. J. Sturm, Y. Ismail, C. J. Stephens, and R. R. Taylor. 1992. Plasma phospholipase A2 activity in clinical acute myocardial infarction. Clin. Exp. Pharmacol. Physiol. 19: 113-118.
22. 2 concentrations in patients with acute myocardial infarction: correlation with tumour necrosis factor-α. Cardiology 94: 106-110.
23. 2 binds to ischemic myocardium during myocardial infarction in humans. Cardiovasc. Res. 53: 138-146.
24. 2 binds to ischemic flip-flopped cardiomyocytes and subsequently induces cell death. Am. J. Physiol. 285: H2218-H2224.
25. 2 inhibitor attenuates NOx production and myocardial damage in the cardiac allograft. J. Heart Lung Transplant. 21: 133.
26. 2 increases atherosclerosis and enhances collagen deposition. J. Lipid Res. 46: 201-210.
27. 2 (IIa) with antiinflammatory activity. Chembiochem. 4: 181-185.
28. 4 receptor antagonist. Br. J. Pharmacol. 140: 71-80.
29. 2 protects rats from TNBS-induced colitis. Int. Immunopharmacol. 5: 883-892.
30. Brown, L., A. Fenning, V. Chan, D. Loch, K. Wilson, B. Anderson, and D. Burstow. 2002. Echocardiographic assessment of cardiac structure and function in rats. Heart Lung Circ. 11: 167-173.
31. Stegemann, H., and K. Stalder. 1967. Determination of hydroxyproline. Clin. Clim. Acta 18: 267-273.
32. 2+ exchange. Naunyn-Schmiedeberg's Arch. Pharmacol. 344: 220-224.
33. 2. Australia Patent AU200172210, International Patent WO200205808.
34. 2 preserve bone architecture following ovariectomy in adult rats. Bone. In press.
35. 2 enzymes in several human tissues. Biochim. Biophys. Acta 1736: 200-210.
36. Ishikawa, Y., K. Komiyama, S. Masuda, M. Murakami, Y. Akasaka, K. Ito, Y. Akishima-Fukasawa, M. Kimura, A. Fujimoto, I. Kudo, and T. Ishii, T. 2005. Expression of type V secretory phospholipase A in myocardial remodelling after infarction. Histopathology 47: 257-267.
37. Nyman, K. M., P. Ojala, V. J. O. Laine, and T. J. Nevalainen. 2000. Distribution of group II phospholipase A2 protein and mRNA in rat tissues. J. Histochem. Cytochem. 48: 1469-1477.
38. De Windt, L. J., P. H. M. Willemsen, S. Popping, G. J. Van der Vusse, R. S. Reneman, and M. Van Bilsen. 1997. Cloning and cellular distribution of a group II phospholipase A2 expressed in the heart. J. Mol. Cell. Cardiol. 29: 2095-2106.
39. 2 isoenzymes in postinfarct congestive heart failure. Am. J. Physiol. 280: C573-C580.
40. Ueno, N., Y. Takegoshi, D. Kamei, I. Kudo, and M. Murakami. 2005. Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem. Biophys. Res. Commun. 338: 70-76.
41. 2. J. Leukocyte Biol. 64: 221-227.
42. Attiga, F. A., P. M. Fernandez, A. T. Weeraratna, M. J. Manyak, and S. R. Patierno. 2000. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce release of matrix metalloproteinases. Cancer Res. 60: 4629-4637.
43. Van Kerckhoven, R., E. A. J. Kalkman, P. R. Saxena, and R. G. Schoemaker. 2000. Altered cardiac collagen and associated changes in diastolic function of infracted rat hearts. Cardiovasc. Res. 46: 316-323.
44. Ishimitsu, T., Y. Uehara, M. Ishii, T. Ikeda, H. Matsuoka, and T. Sugimoto. 1989. Alterations of the cardiovascular and renal prostaglandins and thromboxanes system in prehypertensive spontaneously hypertensive rats. Jpn. Circ. J. 53: 307-312.
45. Sasaki, M., M. T. Hori, T. Hino, M. S. Golub, and M. L. Tuck. 1997. Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat. Am. J. Hypertens. 10: 371-378.
46. Hock, C. E., L. D. Beck, and L. A. Papa. 1992. Peptide leukotriene receptor antagonism in myocardial ischemia and reperfusion. Cardiovasc. Res. 26: 1206-1211.
47. Degousee, N., E. Stefanski, T. F. Lindsay, D. A. Ford, R. Shahani, C. A. Andrews, D. J. Thuerauf, C. C. Glembotski, T. J. Nevalainen, J. Tischfield, and B. B. Rubin. 2001. p38 MAPK regulates group IIa phospholipase A2 expression in interleukin-1β-stimulated rat neonatal cardiomyocytes. J. Biol. Chem. 276: 43842-43849.
48. 2+-dependent phospholipase A2 enzymes. Proc. Natl. Acad. Sci. USA 91: 11060-11064.
49. 1 macrophages. J. Biol. Chem. 271: 6758-6765.
50. 2 block TNF-induced activation of transcription factor nuclear factor-κB and expression of ICAM-1. J. Immunol. 161: 3421-3430.
51. Chaponnier, C., and G. Gabbiani. 2004. Pathological situations characterised by altered actin isoform expression. J. Pathol. 204: 386-395.
52. Koyanagi, M., K. Egashira, S. Kitamoto, W. Ni, H. Shimokawa, M. Takeya, T. Yoshimura, and A. Takeshita. 2000. Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis. Circulation 102: 2243-2248.
53. Nakatsuji, S., J. Yamate, M. Kuwamura, T. Kotani, and S. Sakuma. 1997. In vivo responses of macrophages and myofibroblasts in the healing following isoproterenol-induced myocardial injury in rats. Virchows Arch. 430: 63-69.
54. Vyalov, S., A. Desmouliere, and G. Gabbiani. 1993. GM-CSF-induced granulation tissue formation: relationships between macrophage and myofibroblast accumulation. Virchows Arch. B Cell Pathol. 63: 231-239.
55. Willems, I. E., M. G. Havenith, J. G. De Mey, and M. J. Daemen. 1994. The α-smooth muscle actin-positive cells in healing human myocardial scars. Am. J. Pathol. 145: 868-875.
56. Slama, M., J. Ahn, J. Varagic, D. Susic, and E. Frohlich. 2004. Long-term left ventricular echocardiographic follow-up of SHR and WKY rats: effects of hypertension and age. Am. J. Physiol. 286: H181-H185.
57. Radaelli, A., L. Mircoli, I. Mon, G. Mancia, and A. Ferrari. 1998. Nitric oxide-dependent vasodilation in young spontaneously hypertensive rats. Hypertension 32: 735-739.
58. Stanke-Labesque, F., P. Devillier, S. Veitl, F. Caron, J. Cracowski, and G. Bessard. 2001. Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats. Cardiovasc. Res. 49: 152-160.
59. Shastri, S., J. R. McNeill, T. W. Wilson, R. Poduri, C. Kaul, and V. Gopalakrishnan. 2001. Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR. Am. J. Physiol. 281: H342-H349.
60. Wang, M. H., F. Zhang, J. Marji, B. A. Zand, A. Nasjletti, and M. Laniado-Schwartzman. 2001. CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR. Am. J. Physiol. 280: R255-R261.
61. 2 in aorta of the spontaneously hypertensive rat. J. Cardiovasc. Pharmacol. 33: 605-610.